Eric Miller

Biography
Eric works at the intersection of high-plex proteomics and translational discovery, partnering with leading academic and biopharma groups to implement advanced molecular profiling technologies across oncology, immunology, and complex disease biology. Over the past decade, his collaborative efforts have contributed to studies published in Nature, Nature Genetics, Genome Biology, and Breast Cancer Research, applying new approaches to define tumor microenvironment states, immune programs, and treatment-associated biology. This work has focused on translating high-dimensional molecular data into mechanistic insight and clinically relevant hypotheses. At Nomic, he now concentrates on advancing scalable, quantitative protein profiling to enable large-cohort biomarker discovery, longitudinal monitoring, and mechanism-informed drug development in precision medicine.

Spatial Showcase:
Nomic Bio
Nomic was founded to make biology easier to measure and enable scientists to extend lives by making proteomics accessible, scalable, and routine. The company delivers large-scale, quantitative, and cost-effective protein data through a flexible, end-to-end service—combining customizable content, expert support, and analysis-ready outputs to integrate proteomics seamlessly across drug and biomarker development.